MoneyWorks4Me

Sigachi Industries - Quaterly Results

22 Jul 2022 Evaluate
The sales for the June 2022 quarter moved up 33.29% to Rs. 716.97 millions as compared to Rs. 537.90 millions during the corresponding quarter last year.The Company has registered profit of Rs. 108.87  millions for the quarter ended June 2022, a growth of 22.82%  over Rs. 88.64 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended June 2022 rose to 156.97 millions as compared to 121.41 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 716.97 537.90 33.29 716.97 537.90 33.29 2494.05 1879.42 32.70
Other Income 16.25 1.69 861.54 16.25 1.69 861.54 26.30 32.55 -19.20
PBIDT 156.97 121.41 29.29 156.97 121.41 29.29 530.26 405.89 30.64
Interest 4.74 2.34 102.56 4.74 2.34 102.56 11.55 11.59 -0.35
PBDT 152.23 119.07 27.85 152.23 119.07 27.85 518.71 394.30 31.55
Depreciation 8.02 5.98 34.11 8.02 5.98 34.11 29.05 23.11 25.70
PBT 144.21 113.09 27.52 144.21 113.09 27.52 489.66 371.19 31.92
TAX 35.34 24.45 44.54 35.34 24.45 44.54 109.37 80.60 35.69
Deferred Tax 3.61 4.69 -23.03 3.61 4.69 -23.03 10.53 14.94 -29.52
PAT 108.87 88.64 22.82 108.87 88.64 22.82 380.29 290.59 30.87
Equity 307.43 76.83 300.14 307.43 76.83 300.14 307.43 76.83 300.14
PBIDTM(%) 21.89 22.57 -3.00 21.89 22.57 -3.00 21.26 21.60 -1.55
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..